Quick Answer
Emmaus Life Sciences, Inc. reported Long Term Debt of $587.7 thousand for the year ending 2018.
- This data is from Emmaus Life Sciences, Inc.'s annual report (Form 10-K), filed with the SEC on December 11, 2018.
- XBRL data for this metric is available from 2018 to 2018 (1 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q4 2017: $555.0 thousand | Q4 2017: $559.7 thousand | Q1 2018: $569.0 thousand | Q2 2018: $578.4 thousand | Q3 2018: $587.7 thousand | Q4 2018: $597.1 thousand | Q1 2019: $606.5 thousand | Q2 2019: $615.8 thousand.
- Data sourced from SEC EDGAR public filings as of August 5, 2026.
Last verified: